Overview

A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)

Status:
Completed
Trial end date:
1992-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the antihypertensive efficacy of different doses of losartan compared to placebo and enalapril, in patients with supine diastolic blood pressure of 100-115 mmHg.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Enalapril
Enalaprilat
Losartan